NASDAQ: ACHV
Achieve Life Sciences Inc Stock Ownership - Who owns Achieve Life Sciences?

Insider buying vs selling

Have Achieve Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark K. OkiChief Financial Officer2025-09-1850,060$2.92
$146.18kSell
Richard Alistair StewartChief Executive Officer2025-09-18129,501$2.92
$378.14kSell
Cindy JacobsPresident CMO2025-09-0427,629$2.77
$76.53kSell
Thomas Braxton KingDirector2025-09-04139,858$2.77
$387.41kSell
Jerry WanPrincipal Accounting Officer2025-09-0414,070$2.77
$38.97kSell
Jaime XinosChief Commercial Officer2025-09-0420,854$2.77
$57.77kSell

1 of 1

ACHV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACHV insiders and whales buy or sell their stock.

ACHV Shareholders

What type of owners hold Achieve Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Franklin Resources Inc8.21%4,369,193$11.58MInstitution
Propel Bio Management LLC7.11%3,786,425$10.03MInstitution
Dialectic Capital Management LP6.67%3,549,000$9.40MInsider
Vanguard Group Inc4.65%2,474,312$6.56MInstitution
Robert Schacter3.43%1,827,426$4.84MInsider
Armistice Capital LLC2.99%1,593,188$4.22MInsider
Millennium Management LLC2.55%1,359,116$3.60MInstitution
Simplify Asset Management Inc2.22%1,184,512$3.14MInstitution
Marshall Wace LLP1.91%1,019,281$2.70MInstitution
Ventures West Capital Ltd1.82%968,582$2.57MInsider

1 of 3

ACHV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACHV43.65%19.56%Net Selling
NKTX61.06%38.94%Net SellingNet Selling
HRTX55.63%44.37%Net Buying
VTVT2.07%97.93%Net Buying
TLSA2.64%40.06%

Achieve Life Sciences Stock Ownership FAQ

Who owns Achieve Life Sciences?

Achieve Life Sciences (NASDAQ: ACHV) is owned by 43.65% institutional shareholders, 19.56% Achieve Life Sciences insiders, and 36.79% retail investors. Dialectic Capital Management LP is the largest individual Achieve Life Sciences shareholder, owning 3.55M shares representing 6.67% of the company. Dialectic Capital Management LP's Achieve Life Sciences shares are currently valued at $9.48M.

If you're new to stock investing, here's how to buy Achieve Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.